Market Overview:
The global psoriasis treatment market size is anticipated to touch USD 37,634.2 million by 2026 owing to the increasing number of psoriasis cases. Some studies say that psoriasis may further develop other chronic diseases that cause harm to the immune system of the body. These include non-melanoma skin cancer, psoriatic arthritis, lung cancer, depression, metabolic syndrome, cardiac disorders, COPD (chronic obstructive pulmonary disease), and others. It may also cause polycystic ovarian syndrome and pregnancy complications in women. A recent report by Fortune Business Insights offers a qualitative and quantitative analysis of this market and its growth parameters. As per this report titled, “Psoriasis Treatment Market Size, Share and Industry Analysis By Drug Class (TNF Inhibitors, Interleukins, Others), By Type (Plaque Psoriasis, Psoriatic Arthritis, Others), By Route of Administration (Oral, Parenteral, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online pharmacies), and Regional Forecast 2019-2026,”According to this report, the market value stood at USD 18,378.0 million in 2018 and will exhibit a CAGR of 9.4% between 2019 to 2026.
Request a Sample Copy of the Research Report
COVID-19 Impact
The on-going corona virus pandemic has created an unprecedented health and economic crisis globally. Industries are reporting deflated growth, markets are experiencing a period of great distress, and some businesses are on the verge of shutting down. To tide over these troubled times, Fortune Business Insights™ aims to provide you with precise market intelligence to enable your business to ensure its continued growth.
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this, too, shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. Some industries are struggling, and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are making continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit:https://www.fortunebusinessinsights.com/industry-reports/psoriasis-treatment-market-100600
The report answers the following Questions:
- What is the nature of the market competition?
- How will major investment in novel development and clinical trials positively impact the psoriasis treatment market?
- Which strategies are acquired by vendors to earn the lion’s share in the market?
- Which are the significant industrial trends of the market?
Drivers & Restraints-
Increasing Investment on Development of Biologicals for Treatment will Augment Growth
The World Health Organization predicts the frequency of psoriasis to vary from 0.09% to 11.0% throughout all nations, thereby making it a serious problem worldwide. The increasing prevalence of this disease is a major psoriasis treatment market growth driver. Besides this, the advent of novel biologicals for treating various diseases is also expected to add impetus to the market. Product development, clinical trials, and innovation to cure this non-communicable disease are expected to bode well for the market.
On the negative side, the lack of consensus for treatment outcomes, expensive products, and delays in diagnostic procedures may cause major hindrance to the market in the forecast years. This, coupled with the delays associated with clinical management may also hamper the overall market size.
Nevertheless, heavy investments in research and development for treating psoriasis and a rise in penetration of innovative products will create better growth opportunities in the near future.
Quick Buy Psoriasis Treatment Market
Segment-
TNF Inhibitors Segment to be Overpowered in Forecast Years Due to Declining Prices of Branded Products
Based on segmentation by drug class, the TNF inhibitors segment was dominating the market in the past. In 2018, this segment earned a 46.3% psoriasis treatment market share. However, the advent of bio similar and increasing prescription volume for interleukin inhibitors resulted in a decline in the rate of branded products. Owing to the factor stated above, the interleukin inhibitors segment is likely to overpower the TNF inhibitors segment in the coming years.
Have Any Query? Ask Our Experts
Regional Analysis-
North America to Dominate Market on Account of Presence of Strong Healthcare Facilities
The National Psoriasis Foundation states an estimate of 8 million Americans who are suffering from psoriasis. The increasing number of people suffering from this disease in America and Canada is responsible for the dominance of the North American market. Besides this, the presence of strong healthcare facilities, the adoption of biological therapies at a high rate, and the heavy investments in research and development, and clinical trials are also boosting the regional market.
Europe emerged as the second largest market and Asia Pacific is likely to register faster growth rates in the coming years on account of the rise in geriatric population, improving healthcare and medical facilities, and the adoption of high tech medical equipment for various diagnostic procedures.
Competitive Landscape-
FDA Approvals for Clinical Trails – Key Objective of Players
Companies are engaging in clinical trials, research and development, and other innovative ideas and massively investing in the same to make their mark in the competition. They are also focused on gaining clinical approvals from the Food and Drug Administration (FDA) which will further add more revenue to the market.
Major Industry Developments of the Psoriasis Treatment Market include:
February 2019 – FDA approved the use of TREMFYA, an injector that can be controlled by the patient single-handedly by Janssen Pharmaceuticals, a part of Johnson & Johnson Services Inc., for treating both severe and moderate cases of Psoriasis.
April 2019 – Duobrii the first and only lotion for adults suffering from psoriasis manufactured by Ortho Dermatologics received FDA approval.
Fortune Business Insights™ lists out the names of players operating in this market. They are as follows:
- Amgen Inc.
- Sun Pharmaceutical Industries Ltd.
- Merck & Co., Inc.
- Eli Lilly and Company
- UCB S.A.
- Novartis AG
- LEO Pharma A/S
- CELGENE CORPORATION
- AbbVie Inc.
- Johnson & Johnson Services, Inc.
- Pfizer Inc.
- Other players
About Us
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand current competitive challenges.
Contact Us
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: [email protected]
Author’s Bio
Name- Raginee Sarkar
Raginee currently works as a content writer at Fortune Business Insights™. She comes with extensive experience in writing advertising and marketing content, blogging, film scripting, and news reporting. She strongly believes in quality content and thus prefers to write in a simple, elegant, yet impactful way.
LinkedIn Profile: https://www.linkedin.com/in/raginee-sarkar-5264aa145/
Psoriasis Treatment Market by Drug Class [Tumour Necrosis Factor Inhibitors (Adalimumab, Infliximab and Etanercept), Interleukin-Inhibitors (Ustekinumab, Secukinumab, Ixekizumab and Brodalumab), Vitamin D Analogues (Calcitriol, Calcipotriol and Tacalcitol)], Treatment Type {Topicals [Over-the-counter (OTC) Topicals, Topical Non-Steroids and Topical Steroids], Systemic (Retinoid, Cyclosporine and Methotrexate), Biologics [Tumour Necrosis Factor Alpha (TNF-α) Inhibitors, Interleukin 12 and 23 (IL-12/23) Inhibitors, Interleukin 17 (IL-17) Inhibitor, T cell Inhibitor]} - Forecast till 2027Market SnapshotAs per the analysis by Market Research Future Reports (MRFR), the global psoriasis treatment market is anticipated to garner the market value of USD 13.1 billion, expanding at a CAGR of 7.3% during the assessment period from 2019 to 2025.The psoriasis condition is estimated to be driven by environmental and genetic factors.
The psoriasis treatment market 2020 is predicted to be majorly boosted by the rising awareness regarding the treatment, along with better healthcare infrastructure.
Further, the adoption of a sedentary lifestyle, increased alcohol consumption, smoking, and an unhealthy diet are some of the other vital factors augmenting the global market.
Nevertheless, the growing adoption of alternative psoriasis treatments and the prevailing competition among the key players is projected to enhance the psoriasis treatment market considerably.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/2769 Market SegmentationThe segment evaluation of the global psoriasis treatment market is done by treatment type and drug class.The global market for psoriasis treatment, by drug class, is segmented into Interleukin-inhibitors, tumor necrosis factor inhibitors, and vitamin D analogs.
Moreover, tumor necrosis factor inhibitors are segmented into infliximab, adalimumab, and etanercept.
Vitamin D analogs are segmented into calcipotriol, calcitriol, and tacalcitol.The global market for psoriasis treatment, by treatment, is segmented into systemic, topicals, and biologics.
Hence, the opportunities for consumption remains worthy for players in the global psoriasis treatment market in the coming years.
The current drug pipeline appears to be promising and any launch in the next few years will have a significant impact on the growth of the global psoriasis treatment market.Read Report Overview - https://www.transparencymarketresearch.com/psoriasis-treatment-market.htmlTransparency Market Research has recently published a report on the global psoriasis treatment market.
The potential players in the global psoriasis treatment market include LEO Pharma, AbbVie, AstraZeneca, Pfizer, and Biogen.Rise in Psoriasis Cases to Favor GrowthThe overall number of cases of psoriasis has steadily increased.
This has been one of the largest factors for growth in the global psoriasis treatment market.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=17960While there has been general awareness among the public, governments across the world have taken initiatives to help people suffering from these conditions, especially in the rural areas.
Consistent campaigns and efforts to ensure people from the rural and deeper areas where the access to healthcare is poor, has raised the demand for products in the global psoriasis treatment market.Favorable Healthcare System to Augment Growth in North AmericaUndoubtedly the developed healthcare system in North America, especially the United States, favors growth for the global psoriasis market.
These aspects have a substantial impact on the growth of the global psoriasis treatment market.Request COVID Analysis on Psoriasis Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=17960Besides North America, Europe and Asia Pacific will also remain important for players in the global psoriasis treatment market.
Psoriasis is a common skin disorder and is linked with the immune system.
Stress, cold and skin infection can trigger the condition.Psoriasis usually effect the skin on the scalp, knees and elbows.
A report from WHO suggests that the prevalence rate differs from county to country ranging between 0.09% and 11.43%.
The prevalence rate has increase in recent years, which is fuelling the demand for psoriasis treatment.Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/2769Sales of psoriasis medication, therapeutics and drugs have also increased owing the increased penetration of psoriasis treatment in rural and remote areas in fast developing countries.
The treatment options that are currently available are either offer temporary relief or of symptomatic nature.
At the same time, risk of side-effects from psoriasis drugs continues to be a major challenge for pharmaceutical companies.
